The in vivo form of the murine class VIPOU protein Emb is larger than that encoded by previously described transcripts by Relaix, F et al.
www.elsevier.com/locate/gene
Gene 333 (2004) 35–46The in vivo form of the murine class VI POU protein Emb is larger than
that encoded by previously described transcripts
$
F. Relaixa, S. Molinarib, M. Lemonniera, B. Scha¨ferc, M. Buckinghama,*
aC.N.R.S. URA 2578, Department of Developmental Biology, Pasteur Institute, 75724 Paris Cedex 15, France
bDipartimento di Scienze Biomediche, Universita` degli studi di Modena, 41100 Modena, Italy
cDepartment of Pediatrics, University of Zurich, CH-8032 Zurich, SwitzerlandReceived 25 June 2003; received in revised form 28 November 2003; accepted 5 February 2004
Available online 23 April 2004Abstract
The class VI POU domain family member known as Emb in the mouse (rat Brn5 or human mPOU/TCFh1) is present in vivo as a protein
migrating at about 80 kDa on western blots, considerably larger than that predicted (about 42 kDa) from previously cloned coding sequences.
By RT-PCR and 5V RACE strategies a full-length Emb sequence, Emb FL, is now identified. Shorter sequences encoding the –COOH
terminal, and an –NH2 terminal isoform, EmbN, were also isolated. Comparisons of Emb coding sequences between species, including the
full-length zebra fish, POU(c), are presented, together with a compilation of the multiple transcripts produced by alternative splicing and the
presence of different transcriptional start and stop sites, from the Emb gene.
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1. Introduction Rosenfeld, 1997; Phillips and Luisi, 2000). Many POUThe POU proteins constitute a large family of transcrip-
tion factors, characterized by the presence of a classic
homeobox domain and a POU domain, so-called because it
was first identified in Pit1, Oct1 and Unc86. These two DNA
binding motifs are separated by a linker region of variable
length which confers versatility to DNA binding site recog-
nition and also permits the protein to adopt a number of
conformations leading to different regulatory possibilities.
POU proteins bind as monomers or dimers, may themselves
have transcriptional activation and/or repression domains
and can interact with a wide range of other transcription
factors and co-factors. Seven subclasses of POU domain
proteins have been distinguished, mainly on the basis of the
length and composition of the linker sequence (see Ryan and0378-1119/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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Abbreviations: EST, expressed sequence TAG; cDNA, DNA comple-
mentary to RNA; kDa, kilodalton(s); kb, kilobase(s).
$ The nucleotide sequences reported in this paper have been submitted
to the GenBank TM/EBI Data Bank with accession numbers AY259046
(EmbFL) and AY259047 (EmbN).
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E-mail address: margab@pasteur.fr (M. Buckingham).protein genes are expressed at a high level in the central
nervous system, with lower level expression in other cell
types; Pit1 (class I), for example, is specific to certain types
of neurons and to the pituitary gland, whereas Oct1 (class II)
is ubiquitously expressed. In some cases, target genes are
clearly identified as for Oct1, which is required for activation
of the histone 2B promoter (Hinkley and Perry, 1992).
Mutant analysis has also pointed to a role for a number of
POU proteins, such as Unc86 in C. elegans, or its Brn3
homologues in mammals, in the specification of particular
types of neurons (see McEvilly and Rosenfeld, 2000).
The class VI member designated as Brn5 in rats (Ander-
sen et al., 1993), TCFh1 (Messier et al., 1993) or mPOU
(Wey et al., 1994) in humans and Emb (Okamoto et al.,
1993) or Cns-1 (Bulleit et al., 1994) in mice, has been
described with a sequence of 301–303 amino acids, giving
a protein with an estimated molecular weight of about 40
kDa. It is encoded by a single gene, the structure of which
has been analyzed in mice (Okamoto et al., 1993) and
humans (Messier et al., 1993). The murine Emb gene was
found to have 5/6 exons with an open reading frame of 903
nucleotides, distributed over exons 2–6. The homeodomain
F. Relaix et al. / Gene 333 (2004) 35–4636and 3V part of the POU domain are encoded within exon 6
and the 5Vpart of the POU domain within exon 5 (see also
Messier et al., 1993). Analysis of different cDNA clones
indicated that differential use of an acceptor splice site for
intron 4 resulted in an additional two amino acids in exon 5,
and that a truncated form of the protein (109 amino acids)
was generated from an alternative, internal, ATG in intron 4
(clone C7). Further heterogeneity was observed in the 5V
non-coding sequence, due to use of alternative transcription
initiation sites, resulting in the presence of an additional 5V
exon, exon 1, in cDNA clone C2 (Okamoto et al., 1993). The
reported sizes of mRNA, analyzed on Northern blots—6, 5
and 2 kb—also suggest that a number of transcripts are
generated from the gene (see also Andersen et al., 1993; Wey
et al., 1994). Expression of Emb, based on Northern blots
and in situ hybridization, is high in the brain and also
detected in a number of tissues, including skeletal muscle
and heart (Okamoto et al., 1993; Dominov and Miller, 1996).
Transcripts are present in embryonic, fetal and postnatal
mouse muscle (Dominov and Miller, 1996) and indeed both
Emb and mPOU were cloned from muscle tissue (Wey et al.,
1994; Dominov and Miller, 1996). Differentiating cells of
the C2 and Sol8 muscle cell lines and NIH3T3 and
C3H10T1/2 fibroblast lines also contain Emb mRNA (Dom-
inov and Miller, 1996). In addition to the mammalian
sequence encoding Brn5/mPOU/Emb, a homologue,
POU(c), expressed ubiquitously in the zebra fish embryo,
has been described (Johansen et al., 1993). This sequence
has an open reading frame which extends further 5V, poten-
tially generating a considerably larger protein of 578 amino
acids, with an estimated molecular weight of about 63 kDa.
In this paper, we describe the identification of a number of
transcripts generated from the murine Emb gene including
such a longer sequence sharing strong similarities with the
zebra fish POU(c) sequence. The open reading frame reveals,
in addition to the homeo and POU domain, a third conserved
domain found in bromodomain, containing chromatin remod-
elling proteins such as Brg-1 (Khavari et al., 1993). Western
blot analysis shows that a protein migrating at 80 kDa,
encoded by the longer transcript, is the major endogenous
Emb form present in manymouse tissues, including brain and
muscle, and in cell lines.2. Material and methods
2.1. Cloning of the full-length cDNAS of EmbN and EmbFL
A homology screening of mouse Expressed Sequence Tag
(EST) sequences was carried out using the NCBI TBLASTN
search with the 5V POU(c) protein sequence. The single
mouse EST clone AA009167 was identified and used for
designing the following primers to clone full-length Emb:
MPOUSTOP1: TGCGCCGGCACACGCTGACACT-
GAGCCMPOUSTOP2: TACGGGATCTGAAAGACGTT-
CAGCTTGCTGG
MPOUSSAC2: ATTCCGCGGAGGCAACTGT-
GAAGTCGCTGCCCGG
MPOURSAC2: CTCCGCGGAATGGTCGGGGTCA-
CATGACCCAGC
MPOUSAPA: TGGGGGCCCTGTTGAAGCCAGTG-
GACCTGC
MPOURAPA: AGGGCCCCCACTCTGGGAGCCA-
CCAGCTGCCACAC
MPOUSSAL: AGTCGACGCCCAGCTTCCAGCC-
GAGGAGGAGAGC
MPOURSAL: GCGTCGACTCCCACCTCCAA-
TACTCGGATGG
RT-PCR (using Advantage2 PCR enzyme, conditions
according to the manufacturer’s recommendations, Clon-
tech) was performed using cDNA from E11.5 mouse
embryos as the template. Two PCR fragments were obtained
and cloned into the pGEM-T (Promega) TA cloning vector.
Two rounds of 5VRACE-PCR were performed for each pair
of primers (nested PCR) to obtain full-length cDNA clones
using an E11.5 mouse Marathon Ready cDNA library
(Clontech) as the template. Overlapping 5VRACE products
(1.0, 1.2 and 2 kb) were cloned in the pGEM-T (Promega)
TA cloning vector and sequenced by automated DNA
sequencing in both directions using vector-specific primers
and custom made primers. RT-PCR and RACE products
were assembled by standard cloning techniques. The clon-
ing strategy is diagrammed in Fig. 2.
2.2. Expression vectors
EmbN and EmbFL cDNAs were cloned in the
pCDNA3.1+ vector (Invitrogen) for expression studies.
The Flag-Tag (IBI, Kodak) empty vector was generated
using annealed and phosphorylated oligonucleotides cloned
into pCDNA3.1+. To generate Flag-tagged EmbN and
EmbFL, PCR was utilized to allow in frame standard
cloning into the empty PCDAN3.1-Flag vector, followed
by sequencing.
2.3. Cell culture and transfection experiments
C2/7 is a subclone of the original C2 skeletal muscle cell
line derived from C3H mice (Yaffe´ and Saxel, 1977). C2/7
cells were grown in Dulbecco’s modified Eagle’s medium
(DMEM) containing 20% fetal calf serum (FCS) at low
density and, when approaching confluence, induced to
differentiate with DMEM containing 2% FCS.
The 293 cell line is derived from a human embryonal
kidney cell line (Graham et al., 1977) and was grown in
DMEM containing 20% FCS.
FGC4 is a rat hepatoma cell line (Angrand et al., 1990);
FGC4 cells were cultured in Ham’s modified F12 medium
supplemented with 5% FCS.
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from C3H mice (Reznikoff et al., 1973) and was grown in
DMEM containing 10% FCS.
BC3H is a mouse skeletal muscle-like cell line derived
from a brain tumor (Schubert et al., 1974) ; BC3H cells were
cultured in DMEM containing 20% FCS.
Cells were grown in 100 mm diameter dishes to 50%
confluence and transfected by the calcium phosphate meth-
od (see Biben et al., 1994) using 10 Ag of expression vector.
Precipitates were allowed to form for 30 min at room
temperature. Cells were incubated with the DNA-calcium
phosphate precipitates overnight, then rinsed twice with
DMEM and harvested 48 h after transfection.
2.4. Nuclear and tissue extracts
Nuclear extracts were prepared using a modification of
the method of Dignam et al. (1983) (Ferrari et al., 1994).
Tissue extracts were prepared from embryonic day (E) 11.5
mouse embryos as described previously (Daubas et al.,
2000). Nuclear and cellular extracts were aliquoted and
conserved in liquid nitrogen. Protein concentration was
measured using the method of Bradford (Biorad assay kit).
2.5. Western blot analysis
For the analysis of nuclear or tissue extracts, 10 Ag of
proteins were diluted in 1 SDS gel loading buffer (50mM
Tris–HCl pH 6.8, 100mM dithiothreitol, 2% SDS, 0.1%
bromophenol blue, 10% glycerol) and run in a 10% SDS/
polyacrylamide gel. After electrophoresis, the proteins were
transferred to a poly(vinylidene difluoride) membrane
(Amersham). Filters were blocked by incubation with PBST
(phosphate buffered saline—PBS, containing 0.1% tween-
20), with added 5% low fat dry milk, for 1 h and then
incubated with the primary antibodies (1:1000) for 2 h. The
following antibodies were used: rabbit polyclonal anti-
mPOU antibody and the corresponding pre-immune serum,
mouse monoclonal FLAG antibody (SIGMA). Filters were
extensively washed in PBST and then incubated with
horseradish peroxidase conjugated secondary anti-rabbit or
anti-mouse antibody (Amersham) (1:5000) for 1 h. After
further extensive washes with PBST, antigen–antibody
complexes were visualized with an enhanced chemilumi-
nescence kit (ECL plus, Amersham).
2.6. Immunofluorescence
Thirty-six to forty-eight hours after transfection, cells
were washed extensively with PBS, fixed for 20 min at room
temperature with 3% paraformaldehyde in PBS, permeabi-
lizedwith0.05%TritonX-100 inPBS for 5min, and incubated
for 15 min with PBS containing 1% Bovine Serum Albumin
(BSA). Cells were then incubated overnight at 4 jC with the
monoclonal anti FLAG antibody (1:100), washed with PBS,
incubated for 15 min with 1% BSA in PBS and incubated fora further 60 min with rhodamine conjugated goat anti-mouse
IgG (1:200, Pierce). After extensive washing with PBS, cell
monolayers were mounted in 10 mM Tris–HCl, pH 9, con-
taining 60% glycerol and examined with a Zeiss Axiophot
fluorescence microscope. Images were acquired using a
digital camera and the SPOT32 software package (Diagnostic
Instruments) and exported into Adobe Photoshop.
2.7. Immunoprecipitation
Proliferating C2/C7 cells in 100 mm dishes were trans-
fected with 5 Ag of FLAG-EMBN, FLAG-EMBFL or
FLAG-EMB expression vector; 36 h after transfection, cells
were washed twice with PBS and lysed in 1 ml of lysis
buffer (50 mM Tris–HCl pH 7.4, 150 mM NaCl, 1 mM
EDTA, 1% Triton X-100). The cell lysate was centrifuged
for 10 min at 12,000 g and the supernatant used for
immunoprecipitation. To immunoprecipitate the FLAG fu-
sion proteins, 20 Al of ANTI-FLAG M2 Affinity gel
(SIGMA) were added to the cell lysates and the immuno-
precipitation reaction was left to proceed at 4 jC for 2
h under rotation. The ANTI-FLAG M2 Affinity gel was
collected and washed twice with 1 ml of lysis buffer and
once with 1 ml of 10 mM Tris–HCl, pH 7.5 and 0.1%
NP40. The immunoprecipitated proteins were eluted by
resuspending the affinity gel in 50 Al of 2 SDS gel
loading buffer and boiling for 5 min. The eluted proteins
were run in a 10% SDS polyacrylamide gel and analyzed by
western blot with anti-FLAG or anti-mPOU antibodies.
2.8. In vitro translation
The FLAG-EMBN, FLAG-EMBFL or FLAG-EMB fu-
sion proteins were in vitro translated in the TnT Coupled
Reticulocyte Lysate System (Promega) using plasmid vec-
tors where the coding sequences are under the control of the
bacteriophage T7 RNA polymerase promoter; 1 Ag of
plasmid vector was incubated with 25 Al of TnT lysate, 1
Al of 1 mM amino acid mixture minus methionine, 4 Al of
35S-methionine (1000 Ci/mmol) at 10 mCi/ml, and 1 Al of
T7 TnT RNA polymerase, for 1 h at 30 jC. The products of
the in vitro translation were run in a 10% SDS polyacryl-
amide gel, which was subsequently dried under vacuum and
exposed to an autoradiography film.3. Results
3.1. The size and tissue distribution of the endogenous Emb
protein
In the course of our analysis of a distal enhancer element
situated 5V to the mouse cardiac actin gene, we had
identified a regulatory complex, present in extracts from
the C2 muscle cell line, which includes Emb, a POU
protein, the myogenic regulator Mef2D and the histone
F. Relaix et al. / Gene 333 (2004) 35–4638deacetylase p300 (Molinari et al., 2004). However, on
western blots of the muscle cell extracts, instead of a protein
with the expected size of about 40 kDa (301 amino acids)
(Okamoto et al., 1993; Wey et al., 1994), a protein of 80 kDa
was detected. This is shown in Fig. 1. The antibody used is
directed against the human mPOU protein (Wey et al., 1994)
corresponding to the –COOH terminal part of the Emb
sequence. It is specific for this POU domain class and does
not interact with Oct1 for example (Molinari et al., 2004). In
Fig. 1A, western blots of extracts from different mouse cell
lines are shown. As we had observed previously, in dividing
myoblasts and differentiated myotubes of the C2 muscle cell
line, a major 80 kDa form is seen. This is also the case in
muscle cells of the BC3H cell line and in C3H10T1/2
embryonic fibroblasts. In hepatocytes of the FGC4 line,
two slightly larger bands are seen which are not evident with
the pre-immune serum. In western blots with tissue extractsFig. 1. Detection of Emb isoforms in different cell lines and tissues, by western b
mPOU antibody reveals a band with an apparent molecular weight of 80 kDa prese
BC3H muscle cell line, and dividing myoblasts (mb) and differentiated myotubes (
two slightly larger bands (>80 kDa, asterisks) are detected which are not seen w
different cell lines. (B) The mPOU antibody reveals a major band with an apparent
which is enriched in skeletal muscle, and head (mesencephalon and diencephalon) f
cerebellum (Cer.), where a second band, with a molecular weight of about 42 kDa,
serum. In adult liver and heart, two larger bands (>80 kDa, asterisks) are detected
Other minor bands are detected with the antibody and not the pre-immune serum(Fig. 1B), a major band at 80 kDa is again seen with
preparations from limb, tail, thorax and head of 11.5 day
mouse embryos. Thorax (and limb) are enriched in skeletal
muscle, while the brain (mesencephalon and diencephalon)
is a major component of the head extract. With extracts from
adult cerebellum there is a major 80 kDa protein. In adult
liver and heart, two slightly larger proteins are seen, as in
the case of the liver cell extracts. A larger protein is also just
detectable in adult skeletal muscles. Other minor forms are
also seen. In the cerebellum, the band at about 42 kDa
would also appear to be above background. These observa-
tions suggest alternative splicing of the Emb gene in vivo.
3.2. Identification of further Emb coding sequences
The principal Emb form of about 80 kDa is much larger
than the size predicted by the Emb/Brn5 coding sequenceslot analysis, using an antibody to the human homologue, mPOU. (A) The
nt in nuclear extracts from the mouse embryonic fibroblast line, 10T1/2, the
mt) of the C2 mouse skeletal muscle cell line. In the FGC4 rat liver cell line,
ith the pre-immune serum. Additional minor bands are also detected in the
molecular weight of 80 kDa in tissue preparations of limb, thorax (Th. M.),
rom 11.5-day-old mouse embryos (E11.5). This is also a major form in adult
also appears to be enriched relative to an equivalent band in the pre-immune
. The smaller of the two is detectable in adult skeletal muscle (A. Sk. M.).
in some tissues.
Fig. 2. Cloning strategy to obtain EmbFL and EmbN splice variants. (A) A TBLASTn search using the 5V region of POU(c) revealed a single mouse EST
clone (accession number AA009167) suggesting that Emb (CI, Okamato et al., 1993) may have an incomplete 5Vsequence. (B) RT-PCR on cDNA to RNA
from whole E11.5 mouse embryos gave two major bands of 1.6 and 1.8 kb which were cloned, sequenced and revealed two splice variants of the coding
sequence (sequences in Fig. 3A and B). (C) 5VRACE-PCR using a Matchmaker E11.5 mouse embryo cDNA library (Clontech) was performed to obtain the
full-length 5VUTR (2 kb). The full-length cDNA clones were generated by ligating the RT-PCR product to the 5VRACE products using the silent restriction
sites introduced in the PCR primers. The POU domain is boxed in black, the 5Vacidic domain is indicated as diagonal stripes, other conserved sequences are in
grey. The divergent sequence in EmbN is indicated as vertical stripes.
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transcripts produced by the Emb gene. Previous results on
the expression of Emb/mPOU/Brn5 had been based on
transcript analysis using Emb probes. Since a transcript
with a longer open reading frame, POU(c), had been de-
scribed in zebra fish (Johansen et al., 1993), we looked in
the mouse EST database for sequences homologous to the
POU(c) sequence, lying 5Vto the region which overlaps with
the previously described cDNA clones, C1 and C2 for
mouse Emb (Okamoto et al., 1993). A single mouse EST,
EST AAOO9167, was identified at the time and used to
generate primers, together with 3VEmb sequences, which
were used for 5VRACE PCR and RT-PCR with cDNAs
from embryonic day (E) 11.5 mouse embryos, as indicated
in Fig. 2. Assembly of the RT-PCR and 5VRACE PCR
products resulted in two sequences, EmbFL and EmbN. The
latter corresponds to the –NH2 part of EmbFL, with an
additional divergent 3Vdomain due to alternative splicing.
EmbN has an open reading frame of 180 amino acids and
EmbFL of 578 amino acids. The sequence of EmbFL is
presented in Fig. 3A, and the divergent sequence of the
truncated form, EmbN, in Fig. 3B. In the course of this
study, a large number of new ESTs have appeared in the
databases, confirming that EmbFL encodes a longer form of
Emb which is the most abundant transcript generated by the
Emb gene. However, shorter transcripts such as EmbN or
the other previously described Emb isoforms, although
detectable by RT-PCR experiments (data not shown), appear
to be rare transcripts, not found in the EST databases. Inorder to correlate what is seen on western blots with the
Emb coding sequences, we transfected Emb expression
vectors into cells and identified the resultant protein also
by western blotting. Since EmbN lacks the 3Vpart of Emb
which codes for the –COOH terminal POU domain con-
taining region, recognised by the mPOU antibody, we added
a FLAG tag to the NH2 termini of EmbN, EmbFL and Emb.
Transfection of these sequences into 293 or FGC4 cells,
followed by western blotting of cell extracts, using the anti-
mPOU antibody, shows that EmbFL encodes a protein
which migrates at about 80 kDa, in the FLAG tag fusion
configuration, slightly faster than the endogenous protein
(Fig. 4A), which in 293 cells, used for their high transfec-
tion efficiency, also migrates at 80 kDa. Immunoprecipita-
tion with the FLAG antibody, followed by western blot
analysis with this or the mPOU antibody, confirms the result
for EmbFL and shows that EmbN and Emb sequences
encode proteins which migrate at about 32 and 42 kDa,
respectively (Fig. 4B). In vitro translation of EmbN and
Emb also confirmed this result. In the case of EmbFL it was
difficult to detect full-length (80 kDa) 35S labelled protein
(Fig. 4C). Other observations (not shown) also suggest that
this isoform is susceptible to proteolytic attack following
overexpression in cells.
Immunofluorescent detection of tagged EmbFL or EmbN,
after transfection into C2 muscle cells, showed that the
protein was present in both the nucleus and cytoplasm of
myoblasts and myotubes. In contrast, Emb was mainly
nuclear in these experiments. In some of the transfection
F. Relaix et al. / Gene 333 (2004) 35–4640
Fig. 3. Predicted nucleotide and protein sequence of EmbFL and EmbN. (A) Sequence of EmbFL. Nucleotides and amino acids are numbered on the right. The
POU domain is boxed. About 1 kb of 5VUTR sequence is shown. Known splice sites are indicated by black arrowheads. The entire sequence is reported in
GenBank submission AY259046. (B) Sequence of EmbN. Nucleotides and amino acids are numbered on the right. Known splice sites are indicated by black
arrowheads. The divergent 3Vcoding sequence, generated by a frame shift of this splice variant, is underlined. The entire sequence is reported in GenBank
submission AY259047.
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Fig. 4. Analysis of the proteins encoded by Emb, EmbFL and EmbN sequences. (A) Western blot analysis, using the antibody to the human Emb homologue,
mPOU, with nuclear extracts from the human kidney cell line 293, and from the rat liver cell line, FGC4, transfected with the full-length EmbFL expression
vector (+) or the empty vector ( ). In each case the transfected protein, in the FLAG tagged configuration, migrates slightly faster than the endogenous
protein. (B) Immunoprecipitation of FLAG-fusion proteins. The empty expression vector ( ), full-length Emb (EmbFL), –NH2 terminal form (Emb N)
and –COOH terminal form (Emb) were transfected into myoblasts of the C2 muscle cell line. In (1), the products were revealed with a FLAG antibody
after western blotting of the myoblast extracts. In (2) and (3), the extracts were first immunoprecipitated with the FLAG antibody and revealed with mPOU
antibody (2) or FLAG antibody (3). EmbFL gives a band with an apparent molecular weight of 80 kDa and other smaller bands, EmbN gives a band with
an apparent molecular weight of 30 kDa and Emb of 42 kDa. (C) Autoradiograph of 35S in vitro translated EmbFL, EmbN, Emb and Emb with a FLAG
tag, after separation by gel electrophoresis. A band migrating at 80 kDa is just detectable on in vitro translation of Emb FL. As expected, Emb N gives a
band migrating at 32 kDa and Emb at about 42 kDa.
F. Relaix et al. / Gene 333 (2004) 35–4642experiments, overexpression of EmbN tended to lead to cell
death (data not shown).
3.3. Emb sequence comparisons between mouse and other
species
In Fig. 5, the comparison between EmbFL, EmbN and
the zebra fish sequence POU(c) (Johansen et al., 1993) is
shown. EmbFL probably corresponds to a full-length se-
quence, based on that of POU (c) and also on the size of the
protein encoded in transfection experiments which is similar
to the major endogenous form in most cell types. The DNA
binding domains (610–710) in the –COOH terminal part
are highly conserved. An acidic domain at the –NH2
terminal is also conserved between zebra fish and mouse
sequences. This conserved region is also found in bromo-
domain containing proteins, such as Brg-1 (Khavari et al.,
1993), implicated in chromatin remodelling (Fig. 5B). A
human coding sequence, RDPF-1 (Zhou et al., 1996), also a
member of the class VI family, while clearly not a homo-
logue of mouse EmbFL, shows striking similarities, with
conservation of the DNA binding POU domains and of
some other regions of the sequence, also conserved between
mammalian and zebra fish sequences.
A schematic representation of the isoforms of Emb is
shown in Fig. 6A. The longest mammalian coding sequence
previously described for this protein corresponds to themouse C1/C2 Emb (Okamoto et al., 1993), rat Brn5
(Andersen et al., 1993) or human TCFh1 (Messier et al.,
1993).
Nucleotide alignments to the available human genomic
sequence indicates that the Emb isoforms are encoded by at
least eight exons as indicated in Fig. 6B.4. Discussion
Visualization of the Emb protein by western blotting
shows that it is the large 80 kDa form, referred to as EmbFL
(full length) which accumulates in brain and other tissues
where mammalian Emb/Brn5/mPOU mRNA had previously
been detected. It is therefore a longer transcript, similar to
that described as POU(c) in zebra fish (Johansen et al.,
1993) which is the major sequence expressed from the Emb
gene. As shown here, this extends for a further 821 bp of
open reading frame 5V to the previously identified ATG.
This mammalian sequence has two conserved domains in
the NH2 terminus, the more 5Vof which is an acidic domain
found in bromodomain containing proteins such as Brg1
(Khavari et al., 1993).
Comparison with the human genome sequence indicates
that the coding sequence of EmbFL is composed of at least
eight exons; the numbers of exons in the mouse 5VUTR
sequence, which is diverged from the human, is unknown.
Fig. 5. Comparison of the predicted amino acid sequences of EmbN (mouse), EmbFL (mouse), zebra fish POU(c) (Johansen et al., 1993) and human RDPF-1 (Zhou et al., 1996), another POU VI subfamily protein.
(A) Amino acid sequences are aligned by the CLUSTALW programme (Mac Vector, IBI). Identical amino acids are highlighted in dark grey and similar residues in lighter grey. Dashes represent gaps to bring the
sequences into alignment. Conserved residues between the four protein sequences are represented below the sequence alignments. (B) Alignment of the 5Vconserved mPOU sequence with BRG-1. Identical amino
acids are highlighted in black and similar residues in grey. Dashes represent gaps to bring the sequences into alignment.
F
.
R
ela
ix
et
a
l.
/
G
en
e
3
3
3
(2
0
0
4
)
3
5
–
4
6
4
3
Fig. 6. Protein structure and genomic organisation of all the Emb isoforms identified from different species. (A) Protein domains of Emb isoforms identified as
POU(c) in zebra fish (Dr) (Johansen et al., 1993), mouse(Mm) Emb/C1 (Okamoto et al., 1993) or rat(R) Brn5 (Andersen et al., 1993), mouse C2 and C7
(Okamoto et al., 1993), human (H) TCFh1 (Messier et al., 1993), mouse EmbFL and EmbN, described in this paper. The translation start site methionine (ATG)
is indicated, as well as the predicted and experimental (when known) molecular weight for each isoform on the right. Conserved protein domains are boxed as
indicated. (B) Genomic organisation of the Emb gene based on the mouse Emb/C1, C2 and C7 sequences (Okamoto et al., 1993), the rat Brn5 sequence
(Andersen et al., 1993), the human TCFh1 sequence (Messier et al., 1993) and the mouse data (EmbFL; EmbN) reported in this paper. The non-coding
sequences are indicated as white boxes, coding sequences as black, and the POU domain as grey. The first methionine (ATG) and the stop codon (STOP) are
indicated. The number of 5Vexons (shown as 1n) is unknown since the mouse Emb genomic sequence is not currently available and the 5V UTRs are very
divergent between mouse and human. Schema not to scale.
F. Relaix et al. / Gene 333 (2004) 35–4644As a result of multiple transcription start sites and differen-
tial splicing, several other transcripts are generated from the
gene including the previously described Emb and a shorter
–COOH version (C7), also including the POU and homeo-
domains (Okamoto et al., 1993). These sequences will bind
to DNA, and may act as negative competitors with EmbFL.
The NH2 terminal sequence (EmbN) which lacks these
DNA binding motifs may also regulate EmbFL function.
The possibility of further transcripts, possibly generatedfrom more 5Vgenomic sequence, arises because of the
presence of larger (>80 kDa) forms of EmbFL in extracts
from liver and heart. However, it is also possible that these
reflect secondary modifications which affect EmbFL migra-
tion (e.g. phosphorylation). The 80 kDa protein already
migrates with a higher molecular weight than the 60 kDa
predicted from the coding sequence (see Fig. 6A). This is
frequently observed in acidic proteins, and may also suggest
that the protein is modified. Northern blots had revealed a
F. Relaix et al. / Gene 333 (2004) 35–46 45number of mRNAs hybridizing to the Emb/Brn5/mPOU
sequence, with a 6 kb sequence predominating in most
murine tissues, including brain and striated muscle (Oka-
moto et al., 1993). The open reading frame of EmbFL
requires 1.734 kb of coding sequence and this therefore
implies extensive 3Vor 5Vnon-coding regions if the 6 kbp
corresponds to the processed mRNA; one of the mouse
cDNA clones (C3) isolated by Okamoto et al. (1993), had a
3V non-coding sequence of >4 kb and the longer 5VRACE
product reported here, has 1.8 kb of 5VUTR.
The genes of other POU family members also give rise to
more than one coding sequence. For example, differential
splicing leads to Oct 2 isoforms with different –COOH
termini (Wirth et al., 1991), with and without a transcrip-
tional activation domain (Lillycrop and Latchman, 1992).
In the cell and tissue systems which we have examined,
the longer form of the Emb protein (EmbFL) predominates.
This is confirmed in the EST databases, where EmbFL is
clearly an abundant transcript, whereas EmbN and the other
Emb isoforms previously described are not found as ESTs.
The truncated forms, Emb and EmbN, could potentially
have a dominant negative effect. In the overexpression
experiments described here, no striking change was ob-
served in the transfected cells. This may reflect the inade-
quacies of this artificial approach to the biological function
of POU proteins (see Wu et al., 2001). The possible negative
effect of the truncated EmbN sequence on muscle cell
survival is intriguing in the context of the effects of the
longer (–NH2 terminal) isoform of the class IV POU
domain protein, Brn3a, on the activation of the cell
survival gene BclII. Ectopic expression of Brn5, the trun-
cated –COOH form of EmbFL, has been shown to inhibit
neuronal cell proliferation (Cui and Bulleit, 1997). This
shorter form of Emb has also been variously described as a
weak transcriptional activator (Andersen et al., 1993; Mess-
ier et al., 1993) or as exerting some degree of transcriptional
repression (Wey et al., 1994), possibly through competition
for DNA binding with other POU domain proteins or
indeed with EmbFL. The in vivo significance of these
observations is not clear since the EST data suggest that
the shorter forms of Emb are rare transcripts. However, a
shorter form may accumulate, as well as EmbFL, in the
cerebellum (Fig. 1B). The fact that this form of Emb, when
transfected into cells, appears to be concentrated in the
nucleus may reflect a heightened efficiency for DNA
binding to POU protein targets, compared to EmbFL or
EmbN which, when overexpressed, are not localised exclu-
sively in the nucleus. Overexpression may also lead to
disregulated cellular distribution following interaction of
EmbFL with specific partners.
We have shown (Molinari et al., 2004) that EmbFL binds
to a regulatory sequence in the cardiac actin enhancer, in
the form of a complex with the myogenic factor Mef2D and
the histone transacetylase p300. Mutations, which interfere
with Emb binding, reduce enhancer activity in differentiat-
ing muscle cells and the enhancer is necessary for expres-sion of the cardiac actin gene in skeletal muscle in vivo
(Biben et al., 1996). Furthermore, the sequence to which the
Emb complex binds may be involved in controlling tran-
scriptional accessibility of the locus. In the context of a
transcriptional role for Emb, the homeo and POU domains
are clearly of importance in DNA binding and, potentially,
in providing an interface for interaction with other tran-
scription factors or co-factors (see Phillips and Luisi, 2000).
The conserved regions in the–NH2 terminal domain of
EmbFL are also of potential interest in this context, notably
the acidic sequence which is similar to that in bromodomain
containing proteins such as Brg1 (Khavari et al., 1993),
involved in chromatin remodelling.Acknowledgements
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